Stay updated on Empagliflozin Effects on Cardiac Structure in T2D Clinical Trial

Sign up to get notified when there's something new on the Empagliflozin Effects on Cardiac Structure in T2D Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Empagliflozin Effects on Cardiac Structure in T2D Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    Added Revision: v3.3.2 and removed Revision: v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-28T04:04:51.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    Added a note that publications are automatically filled from PubMed and updated the revision to v3.3.1.
    Difference
    0.1%
    Check dated 2025-11-21T00:37:56.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    Deleted the government funding lapse notice from the page, removing guidance about potential data updates and operating status. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-13T21:40:26.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    Study record details appear unchanged between screenshots; only visual styling and minor layout adjustments are visible. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-10-30T11:59:29.000Z thumbnail image
  6. Check
    69 days ago
    Change Detected
    Summary
    Adds a new version tag (v3.2.0) and removes several drug-related topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) and an older version tag (v3.0.2).
    Difference
    0.3%
    Check dated 2025-10-01T06:12:41.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    Added update: Revision: v3.1.0; Removed topics: Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs, and Revision: v3.0.2. Overall, safety/drug-related sections were removed while a new version label was added.
    Difference
    0.3%
    Check dated 2025-09-30T04:09:20.000Z thumbnail image

Stay in the know with updates to Empagliflozin Effects on Cardiac Structure in T2D Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Empagliflozin Effects on Cardiac Structure in T2D Clinical Trial page.